Denver Health and Hospital Authority

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Denver Health and Hospital Authority sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).

73 total trials 4 currently recruiting 59 completed top decile by trial count

Denver Health and Hospital Authority: 73 sponsored US clinical trials, 4 recruiting.

Denver Health and Hospital Authority sponsors 73 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 59 completed. 10 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, Binge Eating/Purging Type, with 2 trials.

Top-decile sponsor footprint

Denver Health and Hospital Authority ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 56/100

59 of 68 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

73 total, page 1 of 2

RECRUITING NA

Emergency Department Linkage to Care for Patients Experiencing Homelessness

NCT07209072
RECRUITING NA

Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver

NCT07435662
RECRUITING

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

NCT06532734
RECRUITING NA

Blood Flow Restriction Training in Patients With Lower Extremity Fractures

NCT06496035
ACTIVE NOT RECRUITING NA

Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage

NCT04467996
TERMINATED NA

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities

NCT06274359
COMPLETED

Personalized Decision-Aid to Guide Tracheostomy and Prolonged Mechanical Ventilation Decision-Making

NCT07223918
COMPLETED

CGM in Patients With ED's

NCT05603481
COMPLETED NA

Beginning Early and Assertive Treatment for Methamphetamine Use Disorder

NCT06033365
COMPLETED NA

Patient-centered Goal Setting in the National Diabetes Prevention Program

NCT05559515
COMPLETED NA

Micro and Macro Circulation in Sepsis

NCT05694455
COMPLETED NA

Restricted or Liberal Antibiotics After Appendectomy - Denver Health

NCT05002829
COMPLETED NA

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

NCT04797962
COMPLETED Early Phase 1

Inpatient Single Dose Interventions for Alcohol Use Disorder

NCT04562779
COMPLETED Phase 2

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

NCT04357730
COMPLETED NA

Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder

NCT04162184
COMPLETED NA

The DETECT HCV Screening Trial

NCT04003454
COMPLETED NA

The DETECT HCV Linkage to Care Trial

NCT04026867
COMPLETED NA

Presessions for the National Diabetes Prevention Program

NCT04022499
COMPLETED NA

Enhancing Cardiac Rehabilitation Through Behavioral Nudges

NCT03834155
COMPLETED Phase 2

Pupil Dilation for Treatment of IFIS

NCT03760185
COMPLETED NA

Assessing the Impact of Weighted Blankets on Anxiety Among Inpatients With Anorexia Nervosa: a Study Protocol

NCT04191720
COMPLETED NA

Reporting Patient Generated Health Data and Patient Reported Outcomes With Health Information Technology

NCT03386773
TERMINATED Phase 4

Exploration of Pupil Dilation in Horner's Patients Taking Flomax

NCT03615508
COMPLETED NA

Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication

NCT03583931
COMPLETED NA

Multicenter RCT of SSRF in Non Flail Patients

NCT03221595
COMPLETED Phase 4

Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures

NCT03305666
TERMINATED Phase 2

STAT-STatin and Aspirin in Trauma

NCT02901067
COMPLETED Early Phase 1

Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures

NCT02856750
COMPLETED NA

Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)

NCT02794597
COMPLETED

Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

NCT02482051
COMPLETED

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

NCT02796716
COMPLETED NA

Sexual Health Texting Intervention to Support Adolescent Females

NCT02419690
COMPLETED NA

At-risk Intervention and Mentoring Evaluation

NCT02174224
TERMINATED Phase 2

Control of Major Bleeding After Trauma Study

NCT01838863
COMPLETED NA

The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial

NCT01781949
COMPLETED NA

Text Messaging for Weight Loss

NCT02063048
TERMINATED Phase 3

Preventing Alcohol Withdrawal Syndrome With Oral Baclofen

NCT02052440
COMPLETED Phase 4

A Toolbox Approach to Obesity Treatment in Primary Care

NCT01922934
COMPLETED NA

Duration of Antibiotic Treatment for Early VAP (DATE) Trial

NCT01994980
COMPLETED

Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults

NCT01900275
COMPLETED NA

Study of Screening Self-management Goals on Short Term Behavior Change

NCT01936311
COMPLETED

Enteral Feeding in the Post-Injury Open Abdomen

NCT01853735
COMPLETED NA

Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures

NCT01919307
TERMINATED Phase 1

Clinical Trial of Nebulized Hypertonic Saline to Attenuate Post-Traumatic Acute Lung Injury

NCT01667666
COMPLETED NA

Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation

NCT01572220
COMPLETED NA

Community Outreach - Obesity Prevention Trial (CO-OPT)

NCT02024360
TERMINATED Phase 4

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

NCT01362205
COMPLETED NA

Bacterial Contamination of Healthcare Worker Uniforms

NCT01537835
COMPLETED NA

Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management

NCT01391585
Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 5
Phase 3 2
Phase 4 8

Therapeutic Areas

Anorexia Nervosa, Binge Eating/Purging Type 2
PreDiabetes 2
Chronic Stable Heart Failure 1
Intercostal Rib 1
Local Infiltration 1
Pain; Catheter (Other) 1
ARFID 1
Ventilator Acquired Pneumonia 1
Chronic Stable Angina 1
Anorexia Nervosa, Restricting Type 1

What is open in the Denver Health and Hospital Authority pipeline

4 recruiting of 73 indexed (5% open); 59 completed (81%).

Phase mix: 10 late (III/IV) vs 8 early (I/II) (balanced across stages).

Top condition: Anorexia Nervosa, Binge Eating/Purging Type (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Denver Health and Hospital Authority: open-pipeline peers nationwide

Peers matched on 73 registered trials and 5% open enrollment, not the therapeutic-area sidebar.

Denver Health and Hospital Authority sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%10%20%30%40% Total trials Recruiting share Denver Health and Hospital AuthorityHugo W. Moser Research Institute at Kennedy KriegerJoslin Diabetes CenterMassachusetts Eye and Ear InfirmaryTulane UniversityHarvard UniversityBoston CollegeCytoDynDendreon
Denver Health and Hospital Authority sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Denver Health and Hospital Authority sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 73 trials (± recruiting share)

Sponsors near 5% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Denver Health and Hospital Authority page

73 registered trials is a research-attention snapshot, not an endorsement of Denver Health and Hospital Authority or any single study.

  • 4 of Denver Health and Hospital Authority's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anorexia Nervosa, Binge Eating/Purging Type is the condition Denver Health and Hospital Authority studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa, Binge Eating/Purging Type trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Denver Health and Hospital Authority pipeline card: 73 registered trials from official public datasets.Report a data error.